Corrigendum to “Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators”

Gehad Lotfy; Yasmine M. Abdel Aziz; Mohamed M. Said; El Sayed H. El Ashry; El Sayed H. El Tamany; Marwa M. Abu-Serie; Mohamed Teleb; Alexander Dömling; Assem Barakat

doi:10.1016/j.bioorg.2023.107013

Corrigendum to “Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators”

Gehad Lotfy, Yasmine M. Abdel Aziz, Mohamed M. Said, El Sayed H. El Ashry, El Sayed H. El Tamany, Marwa M. Abu-Serie, Mohamed Teleb, Alexander Dömling, Assem Barakat^*

^*Corresponding author for this work

Research output: Contribution to journal › Erratum

55 Downloads (Pure)

Abstract

We have replaced the original Fig. 3 with a revised version, and we sincerely apologize for the inconvenience caused by our oversight. There was a mistaken duplication of the image of compound 5i against the MDA-MB 231 cells with the image for compound 5q against HepG-2 cells. Furthermore, the untreated control images were also changed with higher resolution ones. In the revised Fig. 3, we have corrected this error and provided the accurate representation.

Original language	English
Article number	107013
Number of pages	2
Journal	Bioorganic Chemistry
Volume	143
DOIs	https://doi.org/10.1016/j.bioorg.2023.107013
Publication status	Published - Feb-2024

Access to Document

10.1016/j.bioorg.2023.107013

“Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators”Final publisher's version, 3.65 MBLicence: Taverne

Handle.net

Persistent link

Cite this

Lotfy, G., Abdel Aziz, Y. M., Said, M. M., El Ashry, E. S. H., El Tamany, E. S. H., Abu-Serie, M. M., Teleb, M., Dömling, A., & Barakat, A. (2024). Corrigendum to “Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators”. Bioorganic Chemistry, 143, Article 107013. https://doi.org/10.1016/j.bioorg.2023.107013

@article{6badaef6f9564e118fb8017321b75824,

title = "Corrigendum to “Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators”",

abstract = "We have replaced the original Fig. 3 with a revised version, and we sincerely apologize for the inconvenience caused by our oversight. There was a mistaken duplication of the image of compound 5i against the MDA-MB 231 cells with the image for compound 5q against HepG-2 cells. Furthermore, the untreated control images were also changed with higher resolution ones. In the revised Fig. 3, we have corrected this error and provided the accurate representation.",

author = "Gehad Lotfy and {Abdel Aziz}, {Yasmine M.} and Said, {Mohamed M.} and {El Ashry}, {El Sayed H.} and {El Tamany}, {El Sayed H.} and Abu-Serie, {Marwa M.} and Mohamed Teleb and Alexander D{\"o}mling and Assem Barakat",

note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Inc.",

year = "2024",

month = feb,

doi = "10.1016/j.bioorg.2023.107013",

language = "English",

volume = "143",

journal = "Bioorganic Chemistry",

issn = "0045-2068",

publisher = "Elsevier",

}

Lotfy, G, Abdel Aziz, YM, Said, MM, El Ashry, ESH, El Tamany, ESH, Abu-Serie, MM, Teleb, M, Dömling, A & Barakat, A 2024, 'Corrigendum to “Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators”', Bioorganic Chemistry, vol. 143, 107013. https://doi.org/10.1016/j.bioorg.2023.107013

Corrigendum to “Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators”. / Lotfy, Gehad; Abdel Aziz, Yasmine M.; Said, Mohamed M. et al.
In: Bioorganic Chemistry, Vol. 143, 107013, 02.2024.

Research output: Contribution to journal › Erratum

TY - JOUR

T1 - Corrigendum to “Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators”

AU - Lotfy, Gehad

AU - Abdel Aziz, Yasmine M.

AU - Said, Mohamed M.

AU - El Ashry, El Sayed H.

AU - El Tamany, El Sayed H.

AU - Abu-Serie, Marwa M.

AU - Teleb, Mohamed

AU - Dömling, Alexander

AU - Barakat, Assem

PY - 2024/2

Y1 - 2024/2

N2 - We have replaced the original Fig. 3 with a revised version, and we sincerely apologize for the inconvenience caused by our oversight. There was a mistaken duplication of the image of compound 5i against the MDA-MB 231 cells with the image for compound 5q against HepG-2 cells. Furthermore, the untreated control images were also changed with higher resolution ones. In the revised Fig. 3, we have corrected this error and provided the accurate representation.

AB - We have replaced the original Fig. 3 with a revised version, and we sincerely apologize for the inconvenience caused by our oversight. There was a mistaken duplication of the image of compound 5i against the MDA-MB 231 cells with the image for compound 5q against HepG-2 cells. Furthermore, the untreated control images were also changed with higher resolution ones. In the revised Fig. 3, we have corrected this error and provided the accurate representation.

UR - http://www.scopus.com/inward/record.url?scp=85179785948&partnerID=8YFLogxK

U2 - 10.1016/j.bioorg.2023.107013

DO - 10.1016/j.bioorg.2023.107013

M3 - Erratum

C2 - 38087753

AN - SCOPUS:85179785948

SN - 0045-2068

VL - 143

JO - Bioorganic Chemistry

JF - Bioorganic Chemistry

M1 - 107013

ER -

Corrigendum to “Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators”

Abstract

Access to Document

Handle.net

Other files and links

Fingerprint

Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation: A step towards the next generation p53 activators

Cite this